AzTrials
AzTrials

TinnitusReVA2NCT04987502

Virtual Reality and Subjective Tinnitus

A study testing Virtual Reality and Standard treatment in people with Tinnitus and Tinnitus, Subjective, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test if virtual reality immersion has the potential to significantly decrease subjective tinnitus intrusiveness when compared to standard care. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Tinnitus, Tinnitus, Subjective
What is being tested?
Virtual Reality and Standard treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteFrance
Study dates
7 Sep 2022to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 18 years and < 75 years,
  • French speaking and ability to understand multidimensional questionnaires,
  • Subjective tinnitus of peripheral origin (middle or inner ear auditory nerve)
  • Subjective tinnitus stable and chronic (lasting for more than 6 months)
  • Subjective tinnitus that can be characterized by tinnitus matching
  • Normal hearing or moderate hearing loss

Who cannot join

  • Fluctuating tinnitus,
  • Unilateral or bilateral severe or profound hearing loss,
  • Claustrophobia, visual, impairment, vertigo or dizziness, chronic headache or any other condition contraindicating virtual immersion
  • Psychiatric condition requiring immediate management
  • Pregnant or breastfeeding women
  • Protected adults (including individual under guardianship by court order)
  • Persons deprived of their liberty by judicial or administrative decision

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital européen Georges-Pompidou AP-HP

    Paris, 75015

Other trials in France

About this study

The purpose of this study is to test if virtual reality immersion has the potential to significantly decrease subjective tinnitus intrusiveness when compared to standard care.

Read the detailed description

This is a randomised controlled study aimed at further validating the use of Virtual Reality in the field of subjective tinnitus management. Indeed, earlier results have suggested that this innovative strategy has the potential to be as efficient as a Cognitive and Behavioural Therapy.

Before the sessions, an automated tinnitus matching procedure will help create a sound similar to the tinnitus percept ("Tinnitus Avatar").

During the sessions (8 sessions; 30 minutes), the "Tinnitus Avatar" will be displayed auditorily but also visually - as a sparkling spot - in a variety of virtual 3D auditory and visual environments.

In these virtual environments the patients will be given the possibility to voluntarily control and manipulate the "Tinnitus Avatar" by the means of a wand on top of which the sound and the sparkling will be attached. They will also be able to freely navigate in the virtual scenes where environmental sound will be displayed.

Then the patients will be able to displace at will the "Tinnitus Avatar" in their peri-personal space or mask it by getting close to sounds they may encounter in the virtual scenes.

It is supposed that regaining and training a capacity of interaction with the "Tinnitus Avatar" as if it were a standard sound will help recalibrate the attentional processes involved in tinnitus perception and then to decrease tinnitus intrusiveness.

Being tested
Virtual Reality, Standard treatment
Keywords
Subjective tinnitus, Virtual Reality, Cognitive Behavioral Therapy
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual RealityOther

    8 sessions of virtual reality with 3D audio and visual rendering

  • Standard treatmentBehavioural

    counselling, relaxation techniques, sound enrichment

Study groups in NCT04987502
Study groupRoleWhat they receive
Virtual reality treatmentExperimentalVirtual reality immersion with 3D audio and visual rendering (8 weekly sessions)
Receives: Other: Virtual Reality
Standard treatmentActive comparatorCounselling Relaxation techniques Sound enrichment
Receives: Behavioral: Standard treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Tinnitus Severity Scale (S.T.S.S.)

    16 items multidimensional questionnaire (validated in French) Score 0 to 16 (maximum severity)

    Measured: 5 months

Secondary outcomes (4)
  1. Tinnitus Handicap Questionnaire (THI)

    25 items multidimensional questionnaire (validated in French) Score 0 to 100 (maximum handicap)

    Measured: 5 months

  2. Hospital Anxiety Depression Scale

    14 item questionnaire (validated in French) Score 0 to 21 (maximum anxiety) Score 0 to 21 (maximum depression)

    Measured: 5 months

  3. Visual Analog Scale Tinnitus Loudness

    Likert-Scale 0 to 10 (maximum loudness)

    Measured: 5 months

  4. Visual Analog Scale Tinnitus Intrusiveness

    Likert-Scale 0 to 10 (maximum intrusiveness)

    Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2021
  2. Study start7 Sep 2022
  3. Primary completion31 May 2024
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04987502
Sponsor's protocol ID
APHP210808
Other IDs
2021-A01045-36
Acronym
ReVA2
Status last verified
Feb 2025
First submitted
31 Jul 2021
Last updated
18 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data (IPD) that underlie results in publication could be shared. IPD detailed in the protocol of a planned metaanalysis could be shared

Publications

  • Malinvaud D, Londero A, Niarra R, Peignard P, Warusfel O, Viaud-Delmon I, Chatellier G, Bonfils P. Auditory and visual 3D virtual reality therapy as a new treatment for chronic subjective tinnitus: Results of a randomized controlled trial. Hear Res. 2016 Mar;333:127-135. doi: 10.1016/j.heares.2015.12.023. Epub 2016 Jan 8.

    PubMed 26773752

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality and Standard treatment in people with Tinnitus and Tinnitus, Subjective, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Tinnitus Severity Scale (S.T.S.S.) (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04987502, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in